Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a label 'Revision: v3.4.2' to the page. The previous 'Revision: v3.4.1' label is no longer displayed.
    Difference
    0.0%
    Check dated 2026-02-15T15:07:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added in the page footer, replacing v3.4.0. This is a minor UI update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T09:29:38.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A glossary toggle was added; QA-related labels and capitalization were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the footer now shows 'Revision: v3.4.0'.
    Difference
    0.1%
    Check dated 2026-01-24T04:58:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page metadata shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T03:30:12.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added Location sections for Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Michigan, Minnesota, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Utah, Virginia, West Virginia, New South Wales, South Australia, and Western Australia. The page revision was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-19T12:27:12.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.2 (replacing v3.3.1). No visible changes to study content or page behavior.
    Difference
    0.0%
    Check dated 2025-11-28T00:57:20.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.